Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,201 trials

NCT06793215
Recruiting
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Phase 3 · Argentina, Australia, Belgium, Brazil, Canada, Switzerland, China, Germany, Denmark, Spain, France, United Kingdom, Greece, Hong Kong, Hungary, Ireland, Italy, Japan, South Korea, Mexico, Netherlands, New Zealand, Poland, Portugal, Singapore, Taiwan, United States, South Africa · 299 sites
Registry update: 5 Nov 2026
NCT07220564
Recruiting
A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A
Phase 1 · Austria, Belgium, Switzerland, Germany, Spain, France, United Kingdom, Italy, Poland, Portugal, Sweden, United States · 33 sites
Registry update: 18 Sept 2026
Conflicting statuses (not updated in the registry for 1 month)
NCT07143812
Recruiting
A Study to Evaluate the Safety of a Stem Cell-Based Gene and Cell Therapy in Patients With Newly Diagnosed Glioblastoma
Phase 1 · South Korea · 1 site
Registry update: 22 Jan 2026
NCT07242105
Recruiting
Optimizing Brain Excitability in Depression
Not applicable · United States · 2 sites
Registry update: 10 Feb 2026
NCT07127978
Recruiting
A Study Evaluating the Real-World Experience of Givinostat in Patients With Duchenne Muscular Dystrophy
Not applicable · United States · 9 sites
Registry update: 2 Jul 2026
NCT07101926
Recruiting
Monitoring of Anti-TFPI in Hemophilia
Not applicable · France · 2 sites
Registry update: 23 Mar 2026
NCT07218627
Recruiting
A Research Study on the Effects of NNC0537-1482 in Participants With Heart Failure
Phase 1 · United Kingdom · 1 site
Registry update: 1 Sept 2026
NCT07477431
Recruiting
Levetiracetam for Persons at Risk for Alzheimer's Disease
Phase 2 · Canada · 2 sites
Registry update: 29 Jul 2026
NCT06736899
Recruiting
Trial of Orbital Atherectomy Versus Standard Strategy in Calcified Bifurcation Lesions
Not applicable · Spain · 9 sites
Registry update: 8 Jul 2026
NCT07556874
Recruiting
Descriptive Analysis of Surgeries in Patients With Multiple Osteochondromas
Not applicable · Italy · 1 site
Registry update: 15 May 2026
NCT07195123
Recruiting
Evaluation of the SMART IBD App in Pediatric IBD
Not applicable · United States · 1 site
Registry update: 21 Nov 2025
NCT06222099
Recruiting
The HEARTFELT Study
Not applicable · United States · 3 sites
Registry update: 19 Oct 2026
NCT06628973
Recruiting
Social Prescribing to Improve Adherence and Outcomes in Women With Heart Failure
Not applicable · Canada · 2 sites
Registry update: 20 Feb 2026
NCT07053072
Recruiting
PD-1 mRNA LNP Vaccine for Advanced Primary Hepatocellular Carcinoma.
Phase 1 · China · 2 sites
Registry update: 13 Oct 2026
NCT07091305
Recruiting
A Study of QL1706 Combined With Chemotherapy Induction on Sequential Immunotherapy Consolidation in Patients With Limited-Stage Small Cell Lung Cancer After Chemoradiotherapy
Phase 2 · China · 1 site
Registry update: 11 Jun 2026
NCT07200466
Recruiting
Individualised Endometrial Cancer Risk Stratification by Bayesian Prediction Model (ENDORISK), Optimizing Clinical Implementation
Not applicable · Netherlands · 14 sites
Registry update: 29 Jul 2026
NCT07011914
Recruiting
Care in Multiple Sclerosis (MS)
Not applicable · United States · 6 sites
Registry update: 26 Oct 2026
NCT06555939
Recruiting
Promoting Resilience Among Adolescents and Young Adults With Sickle Cell Disease
Not applicable · United States · 1 site
Registry update: 5 May 2026
NCT07060066
Recruiting
Bilateral Prefrontal and Insular TMS for Depression in Schizophrenia
Not applicable · United States · 1 site
Registry update: 5 Aug 2026
NCT07263386
Recruiting
A Phase II, Multicenter, Randomized, Controlled Clinical Study Comparing the Efficacy and Safety of Sintilimab Plus SOX Versus SOX Alone as Adjuvant Therapy for PD-L1-Positive, Stage pN3 Gastric Cancer
Phase 2 · China · 1 site
Registry update: 4 Dec 2025

Ordered by registry start date. Freshness and sponsorship never change the order.